Monitoring of the action of anti-platelet agent
Matsuda, T.
Rinsho Byori. Japanese Journal of Clinical Pathology Spec no 71: 235-240
1987
ISSN/ISBN: 0047-1860 PMID: 3306045 Document Number: 302751
Document emailed within 1 workday
Related Documents
Carreras, L.O. 1988: Mechanisms of action of anti-platelet agents Sangre 33(6): 505-521La Pesa, M.; Curci, E.; Semeraro, N.; Mancini, L. 1973: Further research on the oncostatic action of a chemotherapeutic agent with anti-folic mechanism (trimethoprim-sulfamethoxazole) Pathologica 65(949): 391-392
Dwivedi, A.; Basu, R.; Chowdhury, S.R.; Goyal, N. 2005: Modulation of estrogen action during preimplantation period and in immature estradiol-primed rat uterus by anti-implantation agent, ormeloxifene Contraception 71(6): 458-464
Seoane, M.R.; De Contardi, N.W. 1971: Action of pyridinolcarbamate on platelet aggregation and adhesive platelet count in normal subjects Prensa Medica Argentina 58(2): 92-99
Pniejnia-Olszyński, W.; Michalski, R. 1977: Blood platelet disorders. II. Acquired thrombocytopathies and action of drugs on platelet function Acta Haematologica Polonica 8(2): 151-156
Arimori, S. 1981: Action mechanism of platelet suppressants and platelet suppressant therapy Nihon Rinsho. Japanese Journal of Clinical Medicine 39(12): 3796-3812
Ikeda, Y.; Furihata, K.; Imai, M.; Sugiura, K.; Toyama, K.; Yamamoto, M.; Watanabe, K.; Ando, Y. 1981: Effect of anti-platelet tubulin antibody on platelet functions Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 44(3): 652-657
Duriez, R.; Hainaut, J.; Gérard, J.P.; Didier, A.; Duret, J.C.; Larroque, P.; Bon, J.F.; Fromantin, M. 1972: Active anti-platelet antibodies in the presence of acetyl-salicylic acid. Activity on platelet aggregation and cross reactions Annales de Medecine Interne 123(6): 593-596
Sun, Y.; Fang, M.; Davies, H.; Hu, Z. 2014: Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 30(3): 169-173
Forest, G. 1984: Effect of anti-HLA-A1 and anti-PLA1 antibodies on the efficacy of platelet transfusion L'Union Medicale du Canada 113(7): 607-609
De Arcangelis, A. 1971: On the use in anti-rheumatic therapy of a new non-steroid anti-inflammatory agent: glucosamide of monohydrated (N-p-chloro-benzoyl-2-methyl-5-methoxy)-indol-3-acetic acid La Clinica Terapeutica 59(3): 229-239
Mishina, Y.; Watada, M. 1974: Studies on fibrinolytic agent-platelet interaction Nihon Ketsueki Gakkai Zasshi: Journal of Japan Haematological Society 37(2): 154-160
Bylin, G. 1989: Platelet activating factor--a new agent to control asthma Lakartidningen 86(8): 620
Tamura, Y.; Hirai, A.; Terano, T.; Saitoh, H. 1992: Anti-thrombotic and anti-atherogenic action of eicosapentaenoic acid Nihon Rinsho. Japanese Journal of Clinical Medicine 50(2): 403-407
Zunnunov, Z.R. 2010: Potentiation of anti-ischemic and anti-anginal action of nitrates by hydrogen sulfide balneotherapy in patients with angina of effort Voprosy Kurortologii Fizioterapii i Lechebnoi Fizicheskoi Kultury 1: 11-14
Santini, P.; Ceccanti, M.; De Lorenzo, A.; Pisculli, M.; Di Giovanni, M.G.; Cavaleri, G.; Attilia, M.L.; Berbellini, A. 1986: Ketanserin (S2-receptor blocking agent), platelet activity and chronic alcoholism International Journal of Clinical Pharmacology Research 6(1): 73-76
Netti, C.; Bandi, G.L.; Pecile, A. 1972: Anti-inflammatory action of proteolytic enzymes of animal vegetable or bacterial origin administered orally compared with that of known anti-phlogistic compounds Il Farmaco; Edizione Pratica 27(8): 453-466
Chagnon, A.; Dalger, J.; Souchet, T.; Woringer, P.; Carpentier, D. 1982: Platelet monitoring in 165 patients treated with heparin La Nouvelle Presse Medicale 11(50): 3731-3732
Strauss, E. 1999: Possible new anti-inflammatory agent Science 286(5438): 209-210
Andréewitch, S. 1997: What anti-depressive agent is best? Lakartidningen 94(28-29): 2529-2530